Skip to main content
. 2018 Apr 14;5(6):677–686. doi: 10.1002/acn3.555

Table 4.

Neuropsychological tests in FRDA and HC

Test FRDA (SD) Controls (SD) Effect size P
MOCA 22.3 (3.6) 26.2 (2.3) 0.33 <0.001
Pointing names 23.9 (0.3) 24 (0.2) 0.02 0.301
Naming nouns 13.9 (1.3) 14.2 (1.2) 0.01 0.568
RCPM 29.6 (6.3) 33 (5.4) 0.08 0.050
Digit Span 7 (4.4) 6.5 (1.1) 0.01 0.454
SPART 18.5 (6.6) 22.9 (3.8) 0.12 0.017
SPART‐D 6.5 (2.4) 8.2 (1.8) 0.13 0.012
RAVLT 40.8 (12.6) 47.5 (9.4) 0.08 0.052
RAVLT‐D 9.3 (3.9) 10.5 (3.4) 0.03 0.250
SLD 26.9 (2.2) 28.5 (1.7) 0.18 0.003
Mental rotation 93.3 (15.9) 105.8 (4.7) 0.15 0.008
SDMT 35.8 (10) 57.3 (13.6) 0.50 <0.001
Attentional matrices 50.5 (8.7) 55.5 (3.2) 0.05 0.118
TMT‐A 67 (68.9) 29.8 (8.8) 0.27 <0.001
TMT‐B 127.3 (57.7) 73.2 (24.2) 0.33 <0.001
Brief Stroop test 50.1 (20.3) 26.9 (7.4) 0.44 <0.001
Semantic fluency 18.5 (5.8) 23.7 (4.9) 0.25 0.001
Phonemic fluency 27.5 (11.7) 41.3 (8.8) 0.31 <0.001

Significance shows the P value of the Mann–Whitney U test. FRDA, Friedreich ataxia patients; HC, healthy controls; MOCA, Montreal Cognitive Assessment; RCPM, Raven Colored Progressive Matrices; SPART, 10/36 Spatial Recall Test; SPART‐D, SPART delayed; RAVLT, Rey Auditory Verbal Learning Test Immediate Recall; RAVLT‐D, RAVLT Delayed Recall; SLD, Segment Length Discrimination; SDMT, Symbol Digit Modalities Test; TMT, Trail Making Test. Significant differences are reported in bold.